1. Home
  2. NVCR vs AVPT Comparison

NVCR vs AVPT Comparison

Compare NVCR & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • AVPT
  • Stock Information
  • Founded
  • NVCR 2000
  • AVPT 2001
  • Country
  • NVCR Switzerland
  • AVPT United States
  • Employees
  • NVCR N/A
  • AVPT N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • AVPT Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • AVPT Technology
  • Exchange
  • NVCR Nasdaq
  • AVPT Nasdaq
  • Market Cap
  • NVCR 1.9B
  • AVPT 3.9B
  • IPO Year
  • NVCR 2015
  • AVPT N/A
  • Fundamental
  • Price
  • NVCR $17.71
  • AVPT $18.12
  • Analyst Decision
  • NVCR Buy
  • AVPT Buy
  • Analyst Count
  • NVCR 6
  • AVPT 5
  • Target Price
  • NVCR $32.83
  • AVPT $17.40
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • AVPT 1.3M
  • Earning Date
  • NVCR 07-24-2025
  • AVPT 08-07-2025
  • Dividend Yield
  • NVCR N/A
  • AVPT N/A
  • EPS Growth
  • NVCR N/A
  • AVPT N/A
  • EPS
  • NVCR N/A
  • AVPT N/A
  • Revenue
  • NVCR $621,711,000.00
  • AVPT $349,012,000.00
  • Revenue This Year
  • NVCR $5.56
  • AVPT $23.25
  • Revenue Next Year
  • NVCR $9.19
  • AVPT $18.07
  • P/E Ratio
  • NVCR N/A
  • AVPT N/A
  • Revenue Growth
  • NVCR 18.27
  • AVPT 21.70
  • 52 Week Low
  • NVCR $14.17
  • AVPT $9.38
  • 52 Week High
  • NVCR $34.13
  • AVPT $20.25
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.32
  • AVPT 52.30
  • Support Level
  • NVCR $17.53
  • AVPT $18.22
  • Resistance Level
  • NVCR $18.70
  • AVPT $19.74
  • Average True Range (ATR)
  • NVCR 0.72
  • AVPT 0.58
  • MACD
  • NVCR 0.09
  • AVPT -0.07
  • Stochastic Oscillator
  • NVCR 60.56
  • AVPT 57.07

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About AVPT AvePoint Inc.

AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.

Share on Social Networks: